BITTIUM BIOSIGNALS OY

Their core work

Bittium Biosignals (formerly Mega Electronics) is a Finnish SME that develops wearable biosignal monitoring devices — particularly EEG and cardiac sensors — for clinical and personal health applications. They provide the hardware and signal processing technology that enables remote patient monitoring in EU health research projects. Their devices feed data into decision support systems for conditions ranging from heart failure to urinary incontinence, positioning them as a key technology supplier in the connected health ecosystem.

What they specialise in

How they've shifted over time

Bittium's H2020 activity spans a narrow window (2015–2019), making long-term evolution hard to assess. Their early involvement focused on eHealth platforms for self-management of chronic conditions (WOMEN-UP), while their later work shifted toward more sophisticated personal health systems combining predictive models, decision support, and cognitive behavioural interventions (HeartMan). This suggests a move from basic remote monitoring toward intelligent, AI-assisted health management systems.

Bittium appears to be moving from general-purpose biosignal hardware toward integrated smart health systems with predictive analytics and patient decision support — valuable for anyone building next-generation remote care platforms.

How they like to work

Bittium primarily joins consortia as a specialist technology partner (2 of 3 projects as participant), providing biosignal hardware and monitoring expertise to larger research teams. They coordinated one small SME Phase 1 project (St. Bernard, €50k), suggesting they can lead focused feasibility studies but prefer contributing their device expertise within broader partnerships. With 17 unique partners across 9 countries from just 3 projects, they integrate well into diverse European consortia.

Despite only three projects, Bittium has built a broad European network of 17 partners across 9 countries, reflecting the large consortium sizes typical of health RIA projects. Their partnerships span clinical centres, universities, and technology firms across the EU.

What sets them apart

Bittium Biosignals brings production-ready wearable biosignal hardware (EEG, ECG) to research consortia — a rare combination of commercial product maturity and willingness to engage in collaborative R&D. Unlike pure research groups, they can supply certified medical-grade devices, making them an ideal partner when a project needs reliable monitoring hardware rather than another prototype. Their Finnish base and SME agility mean faster iteration cycles than larger medtech corporations.

Highlights from their portfolio

• HeartMan
  Largest budget (€493k to Bittium) combining cardiac monitoring with cognitive behavioural therapy and predictive models — an unusually multidisciplinary health project.
• St. Bernard
  Bittium's only coordinated project — an SME Phase 1 feasibility study on emergency EEG diagnostics, signalling their ambition to lead product-driven innovation.